ResourceDrug discovery > Lead Discovery
Successful biopharma production and quality control with automated electrophoresis
20 Dec 2023In this case study from Agilent Technologies, explore how Kaneka Eurogentec, a contract development and manufacturing organization (CDMO) based in Belgium, produces biopharmaceutical critical raw materials including RNA-based, DNA-based, and protein-based biomolecules. Learn how the company's biomolecules, such as mRNAs, are made in current good manufacturing practice (cGMP) facilities, therefore requiring rigorous quality testing throughout production.
Related products
Request Quote for All Products
Fragment Analyzer Systems
Agilent TechnologiesThe Agilent Fragment Analyzer systems are fluorescence-based capillary electrophoresis instruments for the accurate sizing, quantification, and qualification of nucleic acids (DNA and RNA).
Links
Tags
Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Quality ControlQuality control is needed in all production processes. Quality control is a monitoring procedure or set of procedures that are put in place to ensure that a manufactured product adheres to a defined set of quality criteria. BiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.